NOF EUROPE
   

Biolipidure™




  • BiolipidureTM having phospholipid polar groups (Figure 1), 2-methacryloyloxyethyl phosphorylcholine (MPC) polymers, are well known for the suppression of protein adsorption1 and denaturation on the surface.2
  • In previous articles, water-soluble MPC polymer stabilizes the HRP-IgG conjugate3 and the MPC polymer is superior to proteins as a blocking reagent.4
  • BiolipidureTM works as a blocking reagent, a stabilizer and an enhancer for Immunoassay.

  • 1) K. Ishihara, N. P. Ziats, B. P. Tierney, N. Nakabayashi and J. M. Anderson, J.Biomed.Mater.Res., 25, 1397 (1991)
  • 2) K. Ishihara, H. Nomura, T. Mihara, K. Kurita, Y. Iwasaki and N. Nakabayashi, J.Biomed.Mater.Res., 39, 323 (1998)
  • 3) S. Sakaki, N. Nakabayashi and K. Ishihara, J.Biomed.Mater.Res., 47, 523 (1999)
  • 4) S. Sakaki, Y. Iwasaki, N. Nakabayashi and K. Ishihara, Polym.J., 32, 637 (2000)
 

Biolipidure™

- Features - -No danger of biohazards -No difference in lots -Suppression of non-specific adsorption -Stabilization of immobilized antibody
 









What's New
DDS

2010/07/26 Program for Liposome Conference in Vancouver, Aug 4-8, 2010
PDF

2010/07/08 NOF presents at Liposome Conference in Vancouver, Aug 4-8, 2010

2010/06/30
NOF release New Activated PEG

2010/05/21 NOF AMERICA CORPORATION opened a new office in California

On May 7, NOF AMERICA CORPORATION, a wholly owned subsidiary of NOF,
opened a new office in California to further enhance its sales
activities in the North American market
Post Address: 2102 Business Center Drive, Suite 130 Irvine, CA 92612, USA

2010/03/11 NOF partners with ENZON on PEG derivatives PDF

2010/01/07 NOF signs Exclusive Licensing Agreement on Novel Carrier for Gene Delivery PDF